Investor Presentation March 2023

Investment Summary Experienced leadership team aligned with shareholders, successfully implementing a strategy to transform the business Building a fully-integrated drug discovery & development CRO, to support a range of traditional therapies to medical devices to biotherapeutics Delivering a superior client experience (client-centric focus) Driving value through organic growth and acquisitions Providing significant operating leverage and margin expansion potential with increasing revenues and site optimization Creating opportunities to provide full array of product and service offerings to acquired customers 22

View entire presentation